Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dronabinol - Echo Pharmaceuticals

Next Previous
Search
Drug Profile

Dronabinol - Echo Pharmaceuticals

Alternative Names: Delta(9)-tetrahydrocannabinol - Echo Pharmaceutical; Delta(9)-THC - Echo Pharmaceutical; ECP022A (delta9-THC); Namisol

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Echo Pharmaceuticals
  • Developer Echo Pharmaceuticals; University Medical Centre of Nijmegen; VU University Medical Center
  • Class Antidementias; Antiemetics; Antineoplastics; Appetite stimulants; Cannabinoids; Chromans; Muscle relaxants; Non-opioid analgesics; Small molecules
  • Mechanism of Action Cannabinoid receptor agonists; Cannabinoid receptor CB1 agonists; Cannabinoid receptor CB2 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Alzheimer's disease; Anorexia; Multiple sclerosis; Pain

Most Recent Events

  • 25 Feb 2021 Phase-II development is ongoing for Anorexia in Netherlands (Echo Pharmaceuticals pipeline, February 2021)
  • 26 Mar 2019 Echo Pharmaceuticals plans a phase IIb trial for Anorexia in Australia (PO), in May 2019 (ACTRN12619000491167),
  • 01 Dec 2018 Phase-II clinical trials in Anorexia in Netherlands (Echo Pharmaceuticals pipeline, December 2018)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top